Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of Accolade, Inc. (NASDAQ:ACCD – Free Report) by 0.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,802,494 shares of the company’s stock after purchasing an additional 3,501 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned 2.33% of Accolade worth $21,648,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Nordea Investment Management AB increased its holdings in shares of Accolade by 1.4% during the 3rd quarter. Nordea Investment Management AB now owns 106,764 shares of the company’s stock worth $1,148,000 after acquiring an additional 1,423 shares during the last quarter. HighTower Advisors LLC acquired a new position in shares of Accolade during the 3rd quarter worth approximately $2,354,000. Vanguard Group Inc. increased its holdings in shares of Accolade by 3.1% during the 3rd quarter. Vanguard Group Inc. now owns 5,283,858 shares of the company’s stock worth $55,903,000 after acquiring an additional 157,464 shares during the last quarter. Olympiad Research LP acquired a new position in shares of Accolade during the 3rd quarter worth approximately $171,000. Finally, ARK Investment Management LLC increased its holdings in shares of Accolade by 6.3% during the 3rd quarter. ARK Investment Management LLC now owns 6,042,523 shares of the company’s stock worth $63,930,000 after acquiring an additional 358,617 shares during the last quarter. Institutional investors own 84.99% of the company’s stock.
Accolade Price Performance
Shares of ACCD stock opened at $9.21 on Tuesday. The company has a quick ratio of 2.35, a current ratio of 2.35 and a debt-to-equity ratio of 0.48. Accolade, Inc. has a twelve month low of $6.33 and a twelve month high of $17.00. The company has a market cap of $712.95 million, a P/E ratio of -5.58 and a beta of 2.08. The business has a fifty day simple moving average of $9.97 and a 200 day simple moving average of $9.92.
Analyst Ratings Changes
Read Our Latest Report on ACCD
Accolade Profile
Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians.
Featured Articles
- Five stocks we like better than Accolade
- Investing in the High PE Growth Stocks
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Buy P&G Now, Before It Sets A New All-Time High
- Merger or Not, Albertson’s Companies is a Good Buy
- Following Congress Stock Trades
- 3 Cheap Stocks That Shouldn’t Be So
Want to see what other hedge funds are holding ACCD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accolade, Inc. (NASDAQ:ACCD – Free Report).
Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.